Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jan 2002

Burton Eric C, Lamborn Kathleen R, Forsyth Peter, Scott James, O'Campo Jason, Uyehara-Lock Jane, Prados Michael, Berger Mitchel, Passe Sandra, Uhm Joon, O'Neill Brian P, Jenkins Robert B, Aldape Ken D

Abstract excerpt

PURPOSE: Glioblastoma multiforme (GBM) is a highly lethal neoplasm with a median survival of approximately 1 year. Only 2-5% of patients originally diagnosed with GBM will survive > or = 3 years. Whether tumors from these long-term survivors (LTSs) exhibit molecular genetic differences compared with typical GBM survivors is not known. EXPERIMENTAL DESIGN: Tumors from 41 patients initially diagnosed with GBM and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Cell Division

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Immunoenzyme Techniques

Share to Ki-67 Antigen

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-mdm2

Share to Survivors

Source

Identifiers

PMID: 11801556

Genes

STS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.PMID 11801556Read ↗

Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics.Semantic proximity Read ↗

Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysisSemantic proximity Read ↗

Molecular profiling of long-term IDH-wildtype glioblastoma survivors.Semantic proximity Read ↗

Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?Semantic proximity Read ↗

Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma.Semantic proximity Read ↗

[A clinical and molecular study of long-term survival glioblastomas].Semantic proximity Read ↗

Long Term Survival in Patients Suffering from Glioblastoma Multiforme: A Single-Centre Observational Cohort StudySemantic proximity Read ↗

IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.Semantic proximity Read ↗

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.Semantic proximity Read ↗

[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].Semantic proximity Read ↗

p53 mutations versus EGF receptor expression in giant cell glioblastomas.Semantic proximity Read ↗

Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.